(4R,4'R)-2,2'-(Cyclopropane-1,1-diyl)bis(4-(tert-butyl)-4,5-dihydrooxazole), 97%, 1g

2,4-Dichloroquinoline>98.0%(GC)25g

Glycylglycine>99.0%(T)500g

3-(4-Trifluoromethyl-pyridin-2-yl)-benzoic acid, 95.0%, 5g

tert-Butyl 2-oxo-1,2,7,8-tetrahydro-1,6-naphthyridine-6(5H)-carboxylate, 95.0%, 1g

(2-(4-Vinylphenyl)ethene-1,1,2-triyl)tribenzene, 97%, 250mg

(R)-2-((6-(3-((3-(2-cyanobenzyl)-1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)amino)piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile, 98%, 10mg

3-(tert-Butoxycarbonylamino)pyrrolidine>98.0%(GC)(T)25g

Ethyl 4-(4-Chlorophenyl)sulfanylbutanoate, 250mg

2,2-DIMETHYL-1-MORPHOLINOPROPANE-1-THIONE, 95.0%, 500mg

Iodate de sodium, min 99%, pa, 100 g, emballage plastique.

3-(Chloromethyl)-2-hydroxy-5-methylbenzaldehyde, 98%, 1g

5-Methylisoxazole, 97.0%, 5g